Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Proteomic patterns of cervical cancer cell lines, a network perspective.

Higareda-Almaraz JC, Enríquez-Gasca Mdel R, Hernández-Ortiz M, Resendis-Antonio O, Encarnación-Guevara S.

BMC Syst Biol. 2011 Jun 22;5:96. doi: 10.1186/1752-0509-5-96.

2.

Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.

Lee KH, Yim EK, Kim CJ, Namkoong SE, Um SJ, Park JS.

Gynecol Oncol. 2005 Jul;98(1):45-53.

PMID:
15907983
3.

Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.

Kontostathi G, Zoidakis J, Makridakis M, Lygirou V, Mermelekas G, Papadopoulos T, Vougas K, Vlamis-Gardikas A, Drakakis P, Loutradis D, Vlahou A, Anagnou NP, Pappa KI.

Biomed Res Int. 2017;2017:4180703. doi: 10.1155/2017/4180703. Epub 2017 Feb 2.

4.

Proteomic analysis of progressive factors in uterine cervical cancer.

Choi YP, Kang S, Hong S, Xie X, Cho NH.

Proteomics. 2005 Apr;5(6):1481-93.

PMID:
15838902
5.

RbAp48 is a critical mediator controlling the transforming activity of human papillomavirus type 16 in cervical cancer.

Kong L, Yu XP, Bai XH, Zhang WF, Zhang Y, Zhao WM, Jia JH, Tang W, Zhou YB, Liu CJ.

J Biol Chem. 2007 Sep 7;282(36):26381-91. Epub 2007 Jul 6.

6.

Proteomic Analysis of Normal and Cancer Cervical Cell Lines Reveals Deregulation of Cytoskeleton-associated Proteins.

Pappa KI, Lygirou V, Kontostathi G, Zoidakis J, Makridakis M, Vougas K, Daskalakis G, Polyzos A, Anagnou NP.

Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):253-266.

7.

[The possibility of viral etiology in cervical carcinogenesis].

Iwasaka T.

Nihon Sanka Fujinka Gakkai Zasshi. 1990 Aug;42(8):802-11. Japanese.

PMID:
2172417
8.

Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.

De Marco F, Bucaj E, Foppoli C, Fiorini A, Blarzino C, Filipi K, Giorgi A, Schininà ME, Di Domenico F, Coccia R, Butterfield DA, Perluigi M.

PLoS One. 2012;7(3):e34366. doi: 10.1371/journal.pone.0034366. Epub 2012 Mar 28.

10.
11.

Ultra-sensitive high performance liquid chromatography-laser-induced fluorescence based proteomics for clinical applications.

Patil A, Bhat S, Pai KM, Rai L, Kartha VB, Chidangil S.

J Proteomics. 2015 Sep 8;127(Pt A):202-10. doi: 10.1016/j.jprot.2015.05.006. Epub 2015 May 12.

PMID:
25979166
12.

Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array.

Fujimoto T, Nishikawa A, Iwasaki M, Akutagawa N, Teramoto M, Kudo R.

Gynecol Oncol. 2004 May;93(2):446-53.

PMID:
15099960
13.

Identification of 14-3-3zeta associated protein networks in oral cancer.

Matta A, Masui O, Siu KW, Ralhan R.

Proteomics. 2016 Apr;16(7):1079-89. doi: 10.1002/pmic.201500489. Epub 2016 Mar 17.

PMID:
26857332
14.
15.

Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.

Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS.

Gynecol Oncol. 2005 Oct;99(1):26-35.

PMID:
16051329
16.

MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.

Kuncharin Y, Sangphech N, Kueanjinda P, Bhattarakosol P, Palaga T.

Exp Cell Res. 2011 Aug 1;317(13):1830-40. doi: 10.1016/j.yexcr.2011.05.005. Epub 2011 May 24.

PMID:
21640102
17.

Proteomic identification of target proteins following Drosha knockdown in cervical cancer.

Zhou J, Cai J, Huang Z, Ding H, Wang J, Jia J, Zhao Y, Huang D, Wang Z.

Oncol Rep. 2013 Nov;30(5):2229-37. doi: 10.3892/or.2013.2672. Epub 2013 Aug 20.

PMID:
23969986
19.

Gene identification by cDNA arrays in HPV-positive cervical cancer.

Vázquez-Ortíz G, Ciudad CJ, Piña P, Vazquez K, Hidalgo A, Alatorre B, Garcia JA, Salamanca F, Peralta-Rodriguez R, Rangel A, Salcedo M.

Arch Med Res. 2005 Sep-Oct;36(5):448-58.

PMID:
16099320
20.

Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics.

Lee KA, Shim JH, Kho CW, Park SG, Park BC, Kim JW, Lim JS, Choe YK, Paik SG, Yoon DY.

Proteomics. 2004 Mar;4(3):839-48.

PMID:
14997504

Supplemental Content

Support Center